A multidimensional approach to 12-month response to mepolizumab in severe chronic rhinosinusitis with nasal polyps: a real-world single-centre study.

Gutiérrez-Posso JD, Zabala Lopez de Maturana A.

Open source

DOI
10.1159/orl/aegag005
Published
2026-08-31
Container
ORL J Otorhinolaryngol Relat Spec
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/orl/aegag005,
  title = {A multidimensional approach to 12-month response to mepolizumab in severe chronic rhinosinusitis with nasal polyps: a real-world single-centre study.},
  author = {Gutiérrez-Posso JD and  Zabala Lopez de Maturana A.},
  year = {2026},
  journal = {ORL J Otorhinolaryngol Relat Spec},
  doi = {10.1159/orl/aegag005},
  url = {https://doi.org/10.1159/orl/aegag005}
}

RIS

TY  - JOUR
TI  - A multidimensional approach to 12-month response to mepolizumab in severe chronic rhinosinusitis with nasal polyps: a real-world single-centre study.
AU  - Gutiérrez-Posso JD
AU  -  Zabala Lopez de Maturana A.
PY  - 2026
JO  - ORL J Otorhinolaryngol Relat Spec
DO  - 10.1159/orl/aegag005
UR  - https://doi.org/10.1159/orl/aegag005
ER  - 

APA

JD, G., & A., Z. L. D. M. (2026). A multidimensional approach to 12-month response to mepolizumab in severe chronic rhinosinusitis with nasal polyps: a real-world single-centre study.. ORL J Otorhinolaryngol Relat Spec. https://doi.org/10.1159/orl/aegag005

Source records